𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preclinical pharmacokinetics of β-L-dioxolane-cytidine, a novel anticancer agent, in rats

✍ Scribed by Laura E. Moore; F. D. Boudinot; Chung K. Chu

Publisher
Springer
Year
1997
Tongue
English
Weight
198 KB
Volume
39
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics of a novel anti-tum
The pharmacokinetics of a novel anti-tumor agent, β-elemene, in Sprague-Dawley rats
✍ Kun Wang; Zi Li; Yuren Chen; Chengye Su 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

beta-Elemene, a natural sesquiterpene, is a novel anti-tumor agent. The pharmacokinetics of beta-elemene after single i.v. administration have been investigated in male SD rats. beta-Elemene was administered at three doses (50, 75 and 100 mg/kg) and a full pharmacokinetic profile was obtained. beta-

Pharmacokinetic–pharmacodynamic analysis
Pharmacokinetic–pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats
✍ Hisakazu Ohtani; Hitoshi Sato; Tatsuji Iga; Hajime Kotaki; Yasufumi Sawada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Ebastine (EBS), a novel nonsedative antiallergic agent, is similar to terfenadine in its chemical structure. However, clinical arrhythmogenicity of EBS remains controversial. In this study, we evaluated the possible arrhythmogenic potency of EBS as assessed by QT prolongation from a pharmacokinetic-